Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced NSCLC”

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT02284308
What this trial is testing

Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy

Who this might be right for
NSCLC
Maastricht Radiation Oncology 180
Testing effectiveness (Phase 2)Looking for participantsNCT06195189
What this trial is testing

Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II

Who this might be right for
Non Small Cell Lung Cancer
Sichuan University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05118789
What this trial is testing

Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Nuvalent Inc. 359
Large-scale testing (Phase 3)Looking for participantsNCT06564324
What this trial is testing

A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients

Who this might be right for
Non Small Cell Lung Cancer
Nuvation Bio Inc. 194
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06837948
What this trial is testing

Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC

Who this might be right for
Locally Advanced Non-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 160
Testing effectiveness (Phase 2)Ended earlyNCT00321308
What this trial is testing

Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Pfizer 36
Early research (Phase 1)Looking for participantsNCT05194982
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor

Who this might be right for
Locally Advanced or Metastatic Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 570
Early research (Phase 1)UnknownNCT05008861
What this trial is testing

Gut Microbiota Reconstruction for NSCLC Immunotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00701870
What this trial is testing

Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Telik 1
Testing effectiveness (Phase 2)Looking for participantsNCT06348927
What this trial is testing

Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital 52
Early research (Phase 1)Study completedNCT00773188
What this trial is testing

A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 6
Not applicableUnknownNCT04208854
What this trial is testing

Observational Study With Metronomic Oral Vinorelbine in Elderly Patients With Locally Advanced / Metastatic Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Locally Advanced/ Metastatic NSCLC
International Group of Endovascular Oncology 40
Testing effectiveness (Phase 2)Study completedNCT00887783
What this trial is testing

Navelbine And Radiotherapy in Locally Advanced Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Odense University Hospital 117
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07294261
What this trial is testing

Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC

Who this might be right for
Local Advanced or Metastatic NSCLC
Sun Yat-sen University 69
Post-approval studies (Phase 4)Study completedNCT01287754
What this trial is testing

Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 24
Large-scale testing (Phase 3)Study completedNCT03922997
What this trial is testing

Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Hoffmann-La Roche 101
Not applicableActive Not RecruitingNCT03969823
What this trial is testing

Whole Genomic Landscape of Advanced EGFR-mutant NSCLC

Who this might be right for
Locally Advanced or Metastatic NSCLC
Seoul National University Hospital 148
Testing effectiveness (Phase 2)Looking for participantsNCT07486817
What this trial is testing

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

Who this might be right for
Lung Cancer, Non-squamous, Non-small Cell
Boehringer Ingelheim 60
Large-scale testing (Phase 3)Ended earlyNCT00633568
What this trial is testing

Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Carcinoma
European Lung Cancer Working Party 125
Large-scale testing (Phase 3)UnknownNCT05673590
What this trial is testing

Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Beijing Biostar Pharmaceuticals Co., Ltd. 612
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation